(R)-2-Aminopent-4-enoic acid hydrochloride, 95.0%, 250mg

N,N-Bis(pyridin-2-ylmethyl)prop-2-yn-1-amine, 97%, 100mg

1-(5-Methylisoxazol-3-yl)ethanone, 95.0%, 250mg

1-benzyl-6-methyl-2,4(1H,3H)-pyrimidinedione, 95.0%, 250mg

5-Phenylnicotinamide, 95.0%, 250mg

Diphenylacetaldehyde>95.0%(GC)5g

Methyl 5-bromo-4-oxopentanoate, 97%, 5g

4-(Difluoromethoxy)aniline, 98.0%, 5g

Trioctylmethylammonium Chloride (R=C8-C10) [Phase-transfer Catalyst]100g

2-Bromoresorcinol, 95.0%, 1g

3-[4-(Trifluoromethoxy)phenyl]cyclobutane-1-carboxylic acid, 95%, 5g

Methyl 4-bromo-2,6-dimethylbenzoate, 95.0%, 10g

5-Chloro-2-fluorobenzaldehyde, 97.0%, 10g